Show simple item record

dc.contributor.authorDaschner, Álvaro
dc.contributor.authorHerrador, Zaida 
dc.contributor.authorPerteguer-Prieto, Maria Jesus 
dc.contributor.authorBenito, Agustin 
dc.date.accessioned2020-06-04T08:41:59Z
dc.date.available2020-06-04T08:41:59Z
dc.date.issued2019
dc.identifier.citationClin Infect Dis . 2019 Jun 18;69(1):69-76.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/10267
dc.description.abstractThe risk of infection with Anisakis has been recognized for some time, but it is now emerging due to major awareness, better diagnostic techniques, and increasing preference for raw or lightly cooked food. Spain has the second-highest reported incidence after Japan, though the real anisakidosis burden is unknown because of the scarcity of epidemiological data. This study provides a 19-year review of anisakidosis-related hospitalizations describing epidemiological trends and patient characteristics. We performed a retrospective descriptive study using the Spanish Hospitalization Minimum Data Set from 1997 to 2015. Hospitalization rates were calculated and spatial distribution of cases and their temporal behavior were assessed. Clinical characteristics were described, including related codiagnoses and procedures. A total of 2471 hospital discharges were identified. A continuous increasing trend was observed, with several peaks. Most affected communities were located in the northwest inland part of the country. Almost 54% of hospitalized patients were male, with a mean age of 51.3 years. Median length of stay was 5 days, and the hospitalization median cost around €2900. Fatal outcome occurred in 0.5%. Most frequent codiagnoses were digestive diseases, mainly intestinal obstruction. Urticaria, anaphylactic reaction, and angioneurotic edema were only recorded in 2.2%, 2.4%, and 1.2%, respectively. Knowing that hospitalization is unusual in anisakidosis, we offer calculations of the real disease burden. Improving disease surveillance in parallel to disease control will be useful both in gaining extended disease knowledge and reducing morbidity and related costs.es_ES
dc.description.sponsorshipThis work was supported by the European Regional Development Fund from the European Commission (contract number RD12/0018/0001).es_ES
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleEpidemiological Scenario of Anisakidosis in Spain Based on Associated Hospitalizations: The Tip of the Iceberg.es_ES
dc.typeArtículoes_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID30281078es_ES
dc.format.volume69es_ES
dc.format.number1es_ES
dc.format.page69-76es_ES
dc.identifier.doi10.1093/cid/ciy853es_ES
dc.contributor.funderEuropean Regional Development Fund (ERDF/FEDER)
dc.description.peerreviewedes_ES
dc.identifier.e-issn1537-6591es_ES
dc.relation.publisherversionhttps://doi.org/10.1093/cid/ciy853es_ES
dc.identifier.journalClinical infectious diseases : an official publication of the Infectious Diseases Society of Americaes_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/RD12/0018/0001es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-CompartirIgual 4.0 Internacional
This item is licensed under a: Atribución-NoComercial-CompartirIgual 4.0 Internacional